Strategic Plan

blood draw
October 19, 2015

Two Ebola Survivors’ Blood Could Help Vanderbilt Researchers Find A Treatment

By VUMC News and Communications
October 15, 2015

VUSN Alzheimer’s study to explore perception of pain

Vanderbilt University School of Nursing (VUSN) has been awarded a four-year $660,633 grant from the National Institute of Health’s National Institute on Aging to study how psychophysical responses to acute experimental thermal pain differ between older adults with and without Alzheimer’s Disease (AD).

By VUMC News and Communications
October 15, 2015

VUSM seeks to spur medical innovation

Vanderbilt University School of Medicine is accepting applicants into a novel program aimed at students seeking to transform health and health care through medical innovation.

By Jessica Pasley
doctors wearing scrubs with red aids awareness ribbons pinned to shirts
October 8, 2015

Major grant boosts AIDS education, training efforts

Vanderbilt University has been awarded a major federal grant — $16 million over four years — to coordinate AIDS education and training efforts in Tennessee and seven other southeastern states.

By Bill Snyder
October 8, 2015

VUMC poised to transform health care in region

Jeff Balser, M.D., Ph.D., started his annual State of the Medical Center Address last Thursday by affirming that many who work at Vanderbilt University Medical Center (VUMC) feel “called to do so,” often compelled by life-shaping experiences.

By Bill Snyder
flu shot
October 6, 2015

Flu vaccine helps reduce hospitalizations due to influenza pneumonia: study

More than half of hospitalizations due to influenza pneumonia could be prevented by influenza vaccination, according to a study led by investigators at Vanderbilt University Medical Center, published this week in the Journal of the American Medical Association.

By Paul Govern
October 1, 2015

Collaboration seeks to develop new therapies for bone, other diseases

La Jolla Pharmaceutical Co. and Vanderbilt University have signed a research and license agreement covering Vanderbilt’s research program and intellectual property rights related to compounds that block bone morphogenetic protein (BMP) type-I receptors. The compounds have therapeutic potential in a broad range of diseases, including rare genetic disorders.
By Leigh MacMillan
October 1, 2015

Infants born with NAS more likely to be readmitted: Study

Infants diagnosed with drug withdrawal symptoms at birth, also known as neonatal abstinence syndrome (NAS), are nearly 2.5 times as likely to be readmitted to the hospital in the first month after being discharged compared with full-term infants born without complications, according to new Vanderbilt research released in the journal Hospital Pediatrics.
By Christina Echegaray
October 1, 2015

VICC investigators land Komen breast cancer grants

Two Vanderbilt-Ingram Cancer Center (VICC) investigators — Jennifer Pietenpol, Ph.D., B.F. Byrd Jr. Professor of Oncology and director of VICC, and Valerie Jansen, M.D., Ph.D., medical oncology fellow — have received new cancer research grants awarded by Susan G. Komen, the world’s largest nonprofit funder of breast cancer research.
By VUMC News and Communications
September 24, 2015

Team to explore using nanoparticles to fight cancer

Three Vanderbilt researchers have received a federal grant to study the use of nanoparticles to deliver potential therapies for breast cancer that has spread to the bone.
By VUMC News and Communications
September 24, 2015

Study tracks brain’s trigger for overeating high-fat food

Disruptions in a specific signaling pathway in the brain can cause overeating of high-fat food, researchers at Vanderbilt University have found.
By Bill Snyder
September 24, 2015

Stallworth makes select list of brain injury rehab centers

Vanderbilt Stallworth Rehabilitation Hospital’s performance at helping people with traumatic brain injuries reconnect with their lives has received Joint Commission recognition and is now one of only seven rehab centers to achieve specialty accreditation for “traumatic brain injury rehabilitation.”
By Tom Wilemon
September 24, 2015

Cancer therapies’ impact on heart, kidneys explored

Vanderbilt is embarking on a multi-disciplinary approach to understand how promising cancer treatments, specifically certain kinase inhibitors, affect the heart and kidneys.
By Kathy Whitney
1 … 8 9 10 11 12 … 16